We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
176 hedge funds and large institutions have $304M invested in Esperion Therapeutics in 2024 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 50 increasing their positions, 26 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
102% more call options, than puts
Call options by funds: $7.09M | Put options by funds: $3.5M
92% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 26
87% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 30
15% more funds holding
Funds holding: 153 → 176 (+23)
4.52% more ownership
Funds ownership: 67.81% → 72.33% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less capital invested
Capital invested by funds: $336M → $304M (-$32M)
Holders
176
Holders Change
+23
Holders Change %
+15.03%
% of All Funds
2.54%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
56
Increased
50
Reduced
26
Closed
30
Calls
$7.09M
Puts
$3.5M
Net Calls
+$3.59M
Net Calls Change
-$1.14M
Top Buyers
| 1 |
BlackRock
New York
|
+$26.2M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$18.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.54M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.66M |
| 5 |
WCM
Whitefort Capital Management
New York
|
+$5.41M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$36.7M |
| 2 |
D.E. Shaw & Co
New York
|
-$11.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$7.96M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.76M |
| 5 |
Goldman Sachs
New York
|
-$5.76M |
